Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Targeting Trypanosoma brucei FPPS by Fragment-based drug discovery

Trypanosoma brucei (T. brucei) is the causative agent of the Human African Trypanosomiasis (HAT), which is a neglected disease with an endemic occurrence in 36 sub-Saharan African countries. The current standard of care suffers from low efficacy and severe side effects. Therefore, new drugs with bet...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: Münzker Lena
Övriga upphovsmän: Klebe, Gerhard (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Materialtyp: Dissertation
Språk:engelska
Publicerad: Philipps-Universität Marburg 2019
Ämnen:
Pharmakologie, Therapeutik
Farnesylpyrophosphat-Synthase
Trypanosoma brucei
Fragment-basierte Wirkstoffentwicklung
farnesyl pyrophosphate synthase
Fragment-based drug discovery
Pharmacology & therapeutics, prescription drugs
Länkar:PDF-fulltext
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk